FGF23 and type 2 diabetes mellitus: In conclusion, increased levels of circulating FGF-23, in patients with type 2 diabetes and normal to mildly impaired kidney function, is associated with impaired cardiac diastolic function and decreased myocardial perfusion reserve, caused by a decrease in maximal myocardial blood flow during pharmacological vasodilator stress.